← BackPharma-Bio Serv, Inc. · Management Consulting ServicesPBSV
Low riskNext report: Around Jan 28, 2027 (est.)
The short versionA company still losing money with growing sales.
Going well
- Sales up 19% in the latest quarter vs a year ago
- No debt reported
Money moves
- No insider buying or selling in the last 30 days
Facts from SEC filings, not a recommendation.
The business over time
Last 12 quarters, from SEC filings
Sales, Jul '26$2.3M+19% vs a year earlier
Oct '23Tap a barJul '26
Last 12 months: $9.5M, up 3.3% from the 12 months before. Over 5 years, sales shrank about 16% a year.
Business quality
The checklist Warren Buffett-style investors use. Annual numbers for 2025.- MissReturn on equity 15%+Earns a lot on the money owners have in the business.-0.9%
- PassDebt under half of equityNot relying on borrowed money.No debt reported
- MissNet margin 10%+Keeps at least 10 cents of profit from each dollar of sales.-1.1%
- MissProfitable every yearSteady profits, not one good year.5 of 10 years
- MissFree cash flow positiveBrings in more cash than it spends to run and grow.-$222K
- PassShare count not growingNot diluting owners. Falling means buybacks.-0.3% in 3 years
- MissGross margin 40%+Pricing power: sells for well above what it costs to make.32.3%
- Revenue
- $9.0M
- -5.3% vs prior year
- 5-year growth
- -16.0%/yr
- revenue, per year
- Total debt
- None
- 0.00x equity
- Current ratio
- 4.03x
- short-term assets / bills due
From annual reports filed with the SEC. A checklist is a starting point for research, not a verdict.
Latest quarter
Quarter ended Jul 31, 2026- Revenue
- $2.3M
- +19.0% YoY
- EPS
- $0.00
- vs -$0.01
- Op. margin
- -3.1%
- +12.9 pts
- Gross margin
- 29.6%
- +0.3 pts
- Free cash flow
- $60K
- Share count
- -0.1%
- vs a year ago
Insider rating
Last 90 days
No open-market insider buys or sells in the last 90 days.
Weekly insider trendNo trades to chart yet.
Filing buzz
Last 7 days vs normal
0/ 100
- This week
- 0
- Normal week
- 0.2
- vs normal
- 0.0x
SEC filings of any kind. 50 means a normal week.
Share count growthYearly rate, last 3 years
-0.1%Cash runwayAt last year's cash burn
85 monthsDebt to equityLatest balance sheet: debt compared with what owners have
No debt reportedShares outstandingLatest reported
23MNext reportAround Jan 28, 2027 (est.)Estimated from the same quarter last year
- Results filedSep 14
- Results filedJun 15
- Results filedMar 17
- Results filedJan 29
- Results filedSep 15, 2025
Flags and big holders
Offerings 6 months, flags 12 months, holders 90 days
No offerings, red flags or new big holders. Clean record.
Insider trades
Open-market buys and sells, last 90 days
No open-market buys or sells in 90 days. Grants and option exercises are left out.
"Owns after" is the insider's holding right after the trade. Pre-planned (10b5-1) sales are set up months ahead, a weaker signal.